Clinical Trials Directory

Trials / Completed

CompletedNCT05045495

Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath Test

Adult Pilot Study to Establish the Reference Ranges and Optimal Cut-offs for Oral 50g Sucrose Challenge Test & 13C-Sucrose Breath Test for CSID Cases (Previously Diagnosed Sucraid Responders) & Controls (GI Asymptomatic Healthy Volunteers)

Status
Completed
Phase
Study type
Observational
Enrollment
211 (actual)
Sponsor
QOL Medical, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

An adult pilot study to establish the normal reference range and optimal cutoffs for the oral 50g Sucrose Challenge Test (SCT) and the 50g 13C-Sucrose Breath Test (CBT) for patients with CSID and healthy controls. This study will enroll 120 healthy controls and 50 CSID patients. No study drug will be administered during this study.

Detailed description

In an effort to mimic the real-world diagnostic setting for these tests, this study will be conducted virtually using a central site with telemedicine capabilities and electronic data capture software to collect data in real time via a mobile app. Subject will complete 3 visits within 21 days. Eligible subjects will undergo the following tests: 1. 50g 13C-Sucrose Breath Test (CBT) 2. Sucrose Intolerance Hydrogen Methane Breath Test (HBT) 3. Sucrose Challenge Test (SCT) 4. Buccal swab for CSID Genetic Testing (GT) The primary aim is to establish the reference/normal ranges and optimal cutoff values for the SCT and CBT.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSucrose Hydrogen Methane Breath TestSubjects will collect 2 buccal swabs for the sucrase genetic test and then subjects will simultaneously conduct the sucrose challenge test, sucrose hydrogen methane breath test, and the 13C-sucrose following ingestion of 50-grams of sucrose (table sugar) mixed with 8 ounce of water.

Timeline

Start date
2021-08-30
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2021-09-16
Last updated
2022-05-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05045495. Inclusion in this directory is not an endorsement.